Literature DB >> 21555601

Risk factors and preventive interventions for Alzheimer disease: state of the science.

Martha L Daviglus1, Brenda L Plassman, Amber Pirzada, Carl C Bell, Phyllis E Bowen, James R Burke, E Sander Connolly, Jacqueline M Dunbar-Jacob, Evelyn C Granieri, Kathleen McGarry, Dinesh Patel, Maurizio Trevisan, John W Williams.   

Abstract

BACKGROUND: Numerous studies have investigated risk factors for Alzheimer disease (AD). However, at a recent National Institutes of Health State-of-the-Science Conference, an independent panel found insufficient evidence to support the association of any modifiable factor with risk of cognitive decline or AD.
OBJECTIVE: To present key findings for selected factors and AD risk that led the panel to their conclusion. DATA SOURCES: An evidence report was commissioned by the Agency for Healthcare Research and Quality. It included English-language publications in MEDLINE and the Cochrane Database of Systematic Reviews from 1984 through October 27, 2009. Expert presentations and public discussions were considered. STUDY SELECTION: Study inclusion criteria for the evidence report were participants aged 50 years and older from general populations in developed countries; minimum sample sizes of 300 for cohort studies and 50 for randomized controlled trials; at least 2 years between exposure and outcome assessment; and use of well-accepted diagnostic criteria for AD. DATA EXTRACTION: Included studies were evaluated for eligibility and data were abstracted. Quality of overall evidence for each factor was summarized as low, moderate, or high. DATA SYNTHESIS: Diabetes mellitus, hyperlipidemia in midlife, and current tobacco use were associated with increased risk of AD, and Mediterranean-type diet, folic acid intake, low or moderate alcohol intake, cognitive activities, and physical activity were associated with decreased risk. The quality of evidence was low for all of these associations.
CONCLUSION: Currently, insufficient evidence exists to draw firm conclusions on the association of any modifiable factors with risk of AD.

Entities:  

Mesh:

Year:  2011        PMID: 21555601     DOI: 10.1001/archneurol.2011.100

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  91 in total

1.  Positive argument for debate in J Neural Transmission: Alzheimer's disease: are we intervening too late? Yes, by years if not decades.

Authors:  Thomas B Shea; Ruth Remington
Journal:  J Neural Transm (Vienna)       Date:  2012-07-11       Impact factor: 3.575

2.  Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.

Authors:  Zane Jaunmuktane; Simon Mead; Matthew Ellis; Jonathan D F Wadsworth; Andrew J Nicoll; Joanna Kenny; Francesca Launchbury; Jacqueline Linehan; Angela Richard-Loendt; A Sarah Walker; Peter Rudge; John Collinge; Sebastian Brandner
Journal:  Nature       Date:  2015-09-10       Impact factor: 49.962

3.  Health-related Quality of Life, Cognitive Performance, and Incident Dementia in a Community-based Elderly Cohort.

Authors:  Ali Ezzati; Andrea R Zammit; Mindy J Katz; Carol A Derby; Molly E Zimmerman; Richard B Lipton
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

4.  Total daily activity declines more rapidly with increasing age in older adults.

Authors:  Aron S Buchman; Robert S Wilson; Lei Yu; Bryan D James; Patricia A Boyle; David A Bennett
Journal:  Arch Gerontol Geriatr       Date:  2013-08-15       Impact factor: 3.250

5.  Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.

Authors:  Timothy C Durazzo; Niklas Mattsson; Michael W Weiner
Journal:  Nicotine Tob Res       Date:  2015-04-06       Impact factor: 4.244

6.  Alzheimer's Prevention Education: If We Build It, Will They Come? www.AlzU.org.

Authors:  R S Isaacson; N Haynes; A Seifan; D Larsen; S Christiansen; J C Berger; J E Safdieh; A M Lunde; A Luo; M Kramps; M McInnis; C N Ochner
Journal:  J Prev Alzheimers Dis       Date:  2014

7.  The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.

Authors:  A Seifan; R Isaacson
Journal:  J Prev Alzheimers Dis       Date:  2015-10-01

8.  Determinants of Activity Levels in African Americans With Mild Cognitive Impairment.

Authors:  Barry W Rovner; Robin J Casten; Benjamin E Leiby
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jan-Mar       Impact factor: 2.703

Review 9.  Personality and Alzheimer's disease: An integrative review.

Authors:  Antonio Terracciano; Angelina R Sutin
Journal:  Personal Disord       Date:  2019-01

10.  Buttermilk and Krill Oil Phospholipids Improve Hippocampal Insulin Resistance and Synaptic Signaling in Aged Rats.

Authors:  Joao Tomé-Carneiro; M Carmen Crespo; Emma Burgos-Ramos; Cristina Tomas-Zapico; Alba García-Serrano; Pilar Castro-Gómez; Cesar Venero; Inmaculada Pereda-Pérez; Shishir Baliyan; Azucena Valencia; Javier Fontecha; Alberto Dávalos; Francesco Visioli
Journal:  Mol Neurobiol       Date:  2018-02-03       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.